In recent years, with the speed up of drug approval, generic drug consistency evaluation promotion, drug procurement, medical insurance directory adjustment and other pharmaceutical new policies continue to promote the transformation and upgrading of China’s pharmaceutical industry to accelerate, while to the monoclonal antibodies, dual antibodies, ADC as the representative of the booming biopharmaceutical industry, to the upstream of the pharmaceutical equipment industry has brought new opportunities and challenges. 2020 since, domestic pharmaceutical machines and seize the huge import substitution Space, market share gradually increased. So, how will the development of China’s pharmaceutical equipment market in the next few years?

According to the listed pharmaceutical equipment public data we can see that in the past two years, China’s pharmaceutical companies have achieved steady growth, the overall industry boom is relatively high. Some institutions predict that after the epidemic era, domestic pharmaceutical enterprises with performance improvement, good service level, easy maintenance and other advantages can still maintain some growth, at the same time, the rapid development of the biopharmaceutical industry, bioreactors and other equipment demand is also expected to continue to expand, and there is room for import substitution.

Overall, China’s pharmaceutical equipment industry opportunities still exist, the next few years will be in a series of favorable impetus to usher in a long cycle of growth. And the main industry trends or include the following aspects.

1, the domestic market for pharmaceutical equipment will undergo huge changes. At present, China’s pharmaceutical equipment companies are mainly a single equipment supply, and today’s market demand is increasingly focused on efficient production, cost control, reduce the footprint, so in the future to provide a total solution to the number of suppliers will gradually increase. As a pharmaceutical engineering company with ten years of experience, we strive to cooperate with customer needs and provide customers with high-quality, professional integrated engineering projects.

2, the development mode of pharmaceutical equipment enterprises will change. In the past, China’s pharmaceutical machine enterprises are mostly in a rough development mode, bringing such problems as waste of resources, high costs and low overall development of the enterprise. Therefore, the future business model of pharmaceutical enterprises will change, from the rough to lean management direction. We are also growing from “system solution service provider” to “intelligent pharmaceutical delivery”.

3, pharmaceutical equipment will be more “intelligent”. Nowadays, under the goal of reducing costs and increasing efficiency, intelligence has become the development direction of the pharmaceutical equipment industry, through upgrading, pharmaceutical equipment can achieve good intelligent control and remote monitoring and control, the operator can analyze and process the system online, independent completion of some steps or processes. At present, the country has also introduced the encouragement and support policies related to the promotion of intelligent manufacturing, and it is expected that the combination of intelligent production lines and unit operation process equipment of pharmaceutical equipment will become the general trend in the future. IVEN will also improve its innovation capability in the R&D stage, so that it can respond to the market in a timely manner still lack of intelligent technology for equipment. In the production stage to improve production efficiency, reduce production costs, and bring customers a better sense of experience in the production of equipment.

At present, China’s pharmaceutical enterprises in the modernization process, more and more tends to intelligent, energy-saving high-end equipment, some of the performance of the weak, energy-intensive traditional equipment is no longer needed. The future of pharmaceutical equipment enterprises will only be competitive if they continue to innovate and upgrade. As a company with decades of experience, Evon has provided integrated engineering projects for more than 30 pharmaceutical plants and pharmaceutical enterprises around the world, we are striving to catch up with imported high-end equipment, bring Chinese equipment to the world, and together provide a modest contribution to global human health.